Part ii - Photoshop CS6 tutorial showing how to make the custom, record label for a gold record. Republican feud explodes amid DHS funding disaster: What to know Dietitians say you shouldn't take ...

Pfizer said a mid-stage study of its investigational CDK4 inhibitor atirmociclib met its key goal in certain patients with breast cancer. Pfizer on Tuesday said the randomized Phase 2 study met its ...

Placebo-adjusted mean weight loss of 16.3% (39 lbs) at 180 mg and 16.0% (37 lbs) at 240 mg at 44 weeks with no evidence of weight loss plateau in ACCESS II, demonstrating highest efficacy among oral ...

JACKSONVILLE, Fla. – Residents in portions of North Florida, including Duval County, are being asked to conserve water after the St. Johns River Water Management District issued a Phase II ...

WHAT THEY ARE DOING TO COMBAT THE CONSTRUCTION. WITH THE PENN AVENUE PHASE TWO STREETSCAPE PROJECT IS COMPLETE. THIS AREA HERE WILL HAVE NEW SIDEWALKS, TRAFFIC LIGHTS AND A LOT MORE. HOWEVER, BUSINESS ...

Pfizer (PFE) said its Phase 2 study of tilrekimig (PF-07275315), a trispecific antibody for atopic dermatitis, showed positive results. The study met its primary endpoint, with tilrekimig showing a ...

Gibson Oncology, a clinical-stage private pharmaceutical company headquartered in Miami, announced it has entered Phase 2 clinical trials with LMP744 for the treatment of first-time recurrent ...

A Metropolitan Transportation Authority rendering shows a conceptual interior of a future Second Avenue Subway station in Harlem, illustrating platform circulation, train clearances and passenger flow ...

OASIS+ is a suite of six multiple-award, indefinite-delivery/indefinite-quantity contracts with a five-year base period and a five-year option term. The contract ...

Michael Block is a 14 time GLAM Award nominated writer, producer, and host of the podcast Block Talk. Throughout his time in the entertainment industry, he has worked on and off Broadway as a stage ...

More antibodies take aim at seeded propagation. New data ties tangle location to deficits in specific cognitive domains. Three first-in-human studies for antibodies targeting different parts of tau ...

Success rates in phase II and phase III clinical trials are recognized as two of the most powerful drivers of overall efficiency in drug development (Nat. Rev. Drug Discov. 23, 656–657; 2024). With ...